MARKET

PRCT

PRCT

Procept Biorobotics Corp
NASDAQ
30.76
-0.70
-2.23%
After Hours: 31.24 +0.48 +1.56% 19:57 01/02 EST
OPEN
31.66
PREV CLOSE
31.46
HIGH
31.75
LOW
30.60
VOLUME
909.07K
TURNOVER
--
52 WEEK HIGH
89.49
52 WEEK LOW
27.80
MARKET CAP
1.72B
P/E (TTM)
-20.0013
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PRCT last week (1222-1226)?
Weekly Report · 12/29/2025 09:57
Where To Invest In 2026: Top 5 Secular Growth Trends
Seeking Alpha · 12/24/2025 13:30
Interesting PRCT Put And Call Options For February 2026
NASDAQ · 12/22/2025 15:46
Weekly Report: what happened at PRCT last week (1215-1219)?
Weekly Report · 12/22/2025 09:56
PROCEPT BioRobotics Price Target Cut to $47.00/Share From $50.00 by Truist Securities
Dow Jones · 12/18/2025 16:01
PROCEPT BioRobotics Is Maintained at Buy by Truist Securities
Dow Jones · 12/18/2025 16:01
Truist Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $47
Benzinga · 12/18/2025 15:50
Procept BioRobotics price target lowered to $47 from $50 at Truist
TipRanks · 12/18/2025 14:15
More
About PRCT
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Webull offers Procept Biorobotics Corp stock information, including NASDAQ: PRCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRCT stock methods without spending real money on the virtual paper trading platform.